Vise Technologies’s Elanco Animal Health ELAN Stock Holding History

Vise Technologies’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$326K	Buy	+14,566	New	+$352K	﹤0.01%	1638

Other funds holding ELAN

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Black Creek Investment Management Toronto, Ontario, Canada $1.8B AUM 5.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Bowen Hanes & Co Ponte Vedra Beach, Florida $4.43B AUM 31.44% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Vise Technologies's ELAN Position: Q3 2026 in Review

Vise Technologies opened a new position in Elanco Animal Health (ELAN) in Q3 2026: 14,566 shares worth $326K. The stake represents ﹤0.01% of the portfolio and ranks #1638 among its holdings.

302 funds tracked by Wall St. Rank hold ELAN as of Q3 2026.

Vise Technologies held 14,566 shares of Elanco Animal Health worth $326K as of Q3 2026.
Elanco Animal Health was a new Vise Technologies position in Q3 2026.
Elanco Animal Health made up ﹤0.01% of Vise Technologies's portfolio in Q3 2026, its #1638 holding.
302 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2026.

Based on Vise Technologies's 13F filing for Q3 2026, filed 29 Oct 2026.